Physician profile
Kyle D Henderson
NPI 1295776821
$1,116.63
in general payments reported to CMS, 2019-2025
15 companies · $243 in 2025
The $243 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.56 · 2020: $66.13 · 2021: $51.99 · 2022: $21.41 · 2023: $313 · 2024: $327 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $246.02 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $175.72 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $168.48 | 2023-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $118.32 | 2019-2021 | |
| Tris Pharma INC | $83.98 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Merck Sharp & Dohme LLC | $79.69 | 2020-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Pfizer INC. | $45.34 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $40.78 | 2025 | Jornay Pm |
| Boston Scientific Corporation | $35.46 | 2023 | Wavewriter Alpha Prime 16 |
| Alk-Abello, INC | $33.30 | 2023-2024 | Odactra, Grastek |
| Sanofi-Aventis U.S. LLC | $26.55 | 2023 | |
| Sobi, INC | $22.57 | 2024 | |
| Acadia Pharmaceuticals INC | $14.51 | 2024 | Daybue |
| Shire North American Group INC | $13.73 | 2019 | |
| Neos Therapeutics, LP | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.